Literature DB >> 7819982

The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?

C E Counsell1, M J Clarke, J Slattery, P A Sandercock.   

Abstract

OBJECTIVE: To determine whether inappropriate subgroup analysis together with chance could change the conclusion of a systematic review of several randomised trials of an ineffective treatment.
DESIGN: 44 randomised controlled trials of DICE therapy for stroke were performed (simulated by rolling different coloured dice; two trials per investigator). Each roll of the dice yielded the outcome (death or survival) for that "patient." Publication bias was also simulated. The results were combined in a systematic review.
SETTING: Edinburgh. MAIN OUTCOME MEASURE: Mortality.
RESULTS: The "hypothesis generating" trial suggested that DICE therapy provided complete protection against death from acute stroke. However, analysis of all the trials suggested a reduction of only 11% (SD 11) in the odds of death. A predefined subgroup analysis by colour of dice suggested that red dice therapy increased the odds by 9% (22). If the analysis excluded red dice trials and those of poor methodological quality the odds decreased by 22% (13, 2P = 0.09). Analysis of "published" trials showed a decrease of 23% (13, 2P = 0.07) while analysis of only those in which the trialist had become familiar with the intervention showed a decrease of 39% (17, 2P = 0.02).
CONCLUSION: The early benefits of DICE therapy were not confirmed by subsequent trials. A plausible (but inappropriate) subset analysis of the effects of treatment led to the qualitatively different conclusion that DICE therapy reduced mortality, whereas in truth it was ineffective. Chance influences the outcome of clinical trials and systematic reviews of trials much more than many investigators realise, and its effects may lead to incorrect conclusions about the benefits of treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7819982      PMCID: PMC2542663          DOI: 10.1136/bmj.309.6970.1677

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Publication bias in clinical research.

Authors:  P J Easterbrook; J A Berlin; R Gopalan; D R Matthews
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

2.  Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction.

Authors:  L K Hine; N M Laird; P Hewitt; T C Chalmers
Journal:  JAMA       Date:  1989-12-01       Impact factor: 56.272

3.  Publication bias: the case for an international registry of clinical trials.

Authors:  R J Simes
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

4.  Why do we need systematic overviews of randomized trials?

Authors:  R Peto
Journal:  Stat Med       Date:  1987 Apr-May       Impact factor: 2.373

5.  Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.

Authors:  S Yusuf; R Collins; R Peto; C Furberg; M J Stampfer; S Z Goldhaber; C H Hennekens
Journal:  Eur Heart J       Date:  1985-07       Impact factor: 29.983

Review 6.  Large-scale randomized evidence: large, simple trials and overviews of trials.

Authors:  R Peto; R Collins; R Gray
Journal:  Ann N Y Acad Sci       Date:  1993-12-31       Impact factor: 5.691

7.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

8.  Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke.

Authors:  P J Koudstaal; J Stibbe; M Vermeulen
Journal:  BMJ       Date:  1988-12-17

9.  A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease.

Authors:  T F Imperiale; A S Petrulis
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

  9 in total
  24 in total

1.  Thrombolysis for acute ischemic stroke: still a treatment for the few by the few.

Authors:  Joanna M Wardlaw; Richard I Lindley; Steff Lewis
Journal:  West J Med       Date:  2002-05

2.  Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study.

Authors:  Lorenzo P Moja; Elena Telaro; Roberto D'Amico; Ivan Moschetti; Laura Coe; Alessandro Liberati
Journal:  BMJ       Date:  2005-04-07

3.  The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.

Authors:  R Kunz; A D Oxman
Journal:  BMJ       Date:  1998-10-31

Review 4.  Topical NSAIDs for acute musculoskeletal pain in adults.

Authors:  Sheena Derry; R Andrew Moore; Helen Gaskell; Mairead McIntyre; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2015-06-11

5.  Bevacizumab vs ranibizumab-an appraisal of the evidence from CATT and IVAN.

Authors:  F G Ahfat; F H Zaidi
Journal:  Eye (Lond)       Date:  2013-03       Impact factor: 3.775

6.  Calcium antagonists for acute ischemic stroke.

Authors:  Jing Zhang; Jia Liu; Dan Li; Canfei Zhang; Ming Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

7.  Stressful life events and difficulties and onset of breast cancer: case-control study.

Authors:  D Protheroe; K Turvey; K Horgan; E Benson; D Bowers; A House
Journal:  BMJ       Date:  1999-10-16

8.  Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach.

Authors:  C E Green; F G Moeller; J M Schmitz; J F Lucke; S D Lane; A C Swann; R E Lasky; J P Carbonari
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 9.  WITHDRAWN: Ovarian ablation for early breast cancer.

Authors:  Mike J Clarke
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 10.  Prone position for acute respiratory failure in adults.

Authors:  Roxanna Bloomfield; David W Noble; Alexis Sudlow
Journal:  Cochrane Database Syst Rev       Date:  2015-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.